Pneumococcal Vaccines: Challenges and Prospects
Murdoch Children’s Research Institute, Melbourne, VIC 3052, Australia
Department of Paediatrics, University of Melbourne, Parkville, Melbourne, VIC 3010, Australia
Immunobiology and Vaccinology Research Laboratory, First Department of Paediatrics, Aghia Sofia Children’s Hospital, National and Kapodistrian University of Athens, 111527 Athens, Greece
Authors to whom correspondence should be addressed.
Received: 22 February 2019 / Accepted: 25 February 2019 / Published: 27 February 2019
Note: In lieu of an abstract, this is an excerpt from the first page.
Infections with the bacterium Streptococcus pneumoniae
are one of the most common causes of morbidity and mortality in children less than five years of age worldwide, mostly in low- and middle-income countries (LMICs) [...]
This is an open access article distributed under the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).
Share & Cite This Article
MDPI and ACS Style
Licciardi, P.; Papadatou, I. Pneumococcal Vaccines: Challenges and Prospects. Vaccines 2019, 7, 25.
Licciardi P, Papadatou I. Pneumococcal Vaccines: Challenges and Prospects. Vaccines. 2019; 7(1):25.
Licciardi, Paul; Papadatou, Ioanna. 2019. "Pneumococcal Vaccines: Challenges and Prospects." Vaccines 7, no. 1: 25.
Show more citation formats
Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.
[Return to top]
For more information on the journal statistics, click here
Multiple requests from the same IP address are counted as one view.